浩洋股份(300833.SZ):關於紫外線殺菌燈和空氣消毒機的生產許可申請獲批
格隆匯6月22日丨浩洋股份(300833.SZ)公佈,公司關於紫外線殺菌燈和空氣消毒機(紫外線、高效過濾)的生產許可申請於近日獲得廣東省衞生健康委員會批准通過。
公司將嚴格按照相關法律、法規的規定,在本《消毒產品生產企業衞生許可證》的許可範圍內,開展消毒產品的生產和銷售。鑑於相關消毒產品的實際銷售情況將受生產產能、市場開拓、行政審批等多重因素影響,公司目前尚無法預測其對公司未來業績的具體影響,敬請投資者謹慎決策,注意投資風險。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.